ImpriMed: ImpriMed unveils cancer treatment forecast technology
The tech aims to deliver AI-driven drug response prediction to human oncology.
Read full article »
ImpriMed is a California-based company that provides solutions such as AI-powered personalized drug response prediction and sample analysis for pet owners and veterinarians.
Read more